









Markets
/
Stocks
/
nasdaq-neph
/

Nephros Inc

NEPH

4.180USD

+0.120+2.96%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

44.31MMarket Cap

33.39P/E TTM



Nephros Inc

4.180

+0.120+2.96%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

59 / 167

Overall Ranking

179 / 4720

Industry

Professional & Commercial Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

5.500

Target Price

+35.47%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Company’s filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 41.97% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 14.16M.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD 74.00K.%!(EXTRA int=2)

Overvalued

The company’s latest PE is 33.27, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 5.84M shares, decreasing 3.04% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 323.44K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.63.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 8.57, which is higher than the Professional & Commercial Services industry's average of 7.40. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 4.42M, representing a year-over-year increase of 35.89%, while its net profit experienced a year-over-year increase of 182.01%.

Score

Industry at a Glance

Previous score

8.57

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.24

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.43

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.17

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 1.65, which is lower than the Professional & Commercial Services industry's average of 2.38. Its current P/E ratio is 32.32, which is -104.46% below the recent high of -1.44 and 146.38% above the recent low of -14.99.

Score

Industry at a Glance

Previous score

1.65

Change

-0.05

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 59/167

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 8.00, which is higher than the Professional & Commercial Services industry's average of 7.62. The average price target for Nephros Inc is 5.50, with a high of 6.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

5.500

Target Price

+35.47%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Nephros Inc

NEPH

Waste Management Inc

Republic Services Inc

RSG

Waste Connections Inc

WCN

Veralto Corp

VLTO

GFL Environmental Inc

GFL

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 7.22, which is lower than the Professional & Commercial Services industry's average of 7.29. Sideways: Currently, the stock price is trading between the resistance level at 4.79 and the support level at 3.47, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.22

Change

0.16

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.025

Neutral

RSI(14)

52.605

Neutral

STOCH(KDJ)(9,3,3)

27.177

Sell

ATR(14)

0.430

Low Volatility

CCI(14)

-19.631

Neutral

Williams %R

57.534

Sell

TRIX(12,20)

0.371

Sell

StochRSI(14)

36.521

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

4.236

Sell

MA10

4.225

Sell

MA20

4.132

Buy

MA50

3.864

Buy

MA100

3.484

Buy

MA200

2.560

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 5.00, which is lower than the Professional & Commercial Services industry's average of 7.77. The latest institutional shareholding proportion is 55.12%, representing a quarter-over-quarter decrease of 3.09%. The largest institutional shareholder is The Vanguard, holding a total of 323.44K shares, representing 3.05% of shares outstanding, with 59.28% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Wexford Capital LP

3.60M

Topline Capital Management, LLC

422.09K

+0.52%

Pessin (Sandra F)

369.71K

-13.91%

Pessin (Norman H)

344.13K

The Vanguard Group, Inc.

Star Investors

204.16K

+1.07%

Bard Associates Inc.

143.22K

-7.76%

Amron (Arthur H)

125.88K

Spandow (Oliver J)

114.84K

Pessin (Brian L.)

95.69K

-4.01%

Geode Capital Management, L.L.C.

90.29K

+6.41%

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 4.05, which is lower than the Professional & Commercial Services industry's average of 4.25. The company's beta value is 1.30. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.